Cargando…
Reduction in hsCRP levels is associated with decreased incidence of cardiovascular events in Japanese hypertensive women but not in men
To test our hypothesis that the magnitude of reduction in hsCRP achieved by antihypertensive medications may predict the benefit for cardiovascular outcomes in hypertensive individuals, we performed subanalysis of the ATTEMPT-CVD study. The hypertensive participants enrolled in the ATTMEPT-CVD study...
Autores principales: | Kim-Mitsuyama, Shokei, Soejima, Hirofumi, Yasuda, Osamu, Node, Koichi, Jinnouchi, Hideaki, Yamamoto, Eiichiro, Sekigami, Taiji, Ogawa, Hisao, Matsui, Kunihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550334/ https://www.ncbi.nlm.nih.gov/pubmed/33046765 http://dx.doi.org/10.1038/s41598-020-73905-4 |
Ejemplares similares
-
Cardiovascular and renal protective role of angiotensin blockade in hypertension with advanced CKD: a subgroup analysis of ATTEMPT-CVD randomized trial
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2018) -
Total adiponectin is associated with incident cardiovascular and renal events in treated hypertensive patients: subanalysis of the ATTEMPT-CVD randomized trial
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2019) -
HsCRP in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Alavi, S A, et al.
Publicado: (2011) -
IL-6 and hsCRP in Somatic Symptom Disorders and related disorders
por: van der Feltz-Cornelis, Christina M., et al.
Publicado: (2020) -
The Authors Reply:
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2013)